Buy or sell: Over the past three weeks, the Nifty Index has demonstrated a strong recovery, fueled by Foreign Institutional Investors (FIIs) purchasing stocks worth â‚ą30,000 crore in the cash market. This bullish momentum was underpinned by both global and domestic factors, notably U.S. President Donald Trump’s decision to pause the implementation of steep reciprocal…
Buy or Sell: The Nifty Index ended the week at 23,519, holding firmly above the critical support level of 23,000. The Indian stock market closed with marginal gains, but investor sentiment remained subdued due to concerns surrounding U.S. economic indicators and trade policies. Also Read | Wipro’s mega deal win ushers confidence, but it has…
Representational image of Aurobindo Pharma’s Unit IX in Andhra Pradesh | Photo Credit: A. Roy Chowdhury The U.S. Food and Drug Administration (U.S. FDA) has classified a warehouse of Aurobindo Pharma subsidiary in New Jersey, U.S. as Official Action Indicated (OAI) after an inspection it conducted. Such a classification means regulatory and/or administrative actions are…
Here’s a quick look at stocks likely to be in focus in today’s trade. ITC: Diversified conglomerate ITC Ltd announced a 7 percent year-on-year (YoY) decline in consolidated net profit for the quarter ended December 31, 2024, at â‚ą4,935 crore. This profit is attributable to the owners of the company. In the corresponding quarter of…
